SUBSEQUENT EVENTS	6 Months Ended
Jun. 30, 2025
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. Included in this legislation are provisions that allow for the immediate expensing of domestic United States research and development expenses and acceleration of tax deductions for qualified capital expenditures acquired and placed into service after January 19, 2025, and other changes to the U.S. taxation of profits derived from foreign operations. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. We are currently evaluating the impact of the new legislation but do not anticipate a significant impact to our consolidated financial statements. During July and August 2025, the Company sold 6,109,714 shares of our common stock under the Second Equity Distribution Agreement at an average price of $13.45 per share for $82.2 million of gross proceeds. The commissions and offering costs borne by the Company were approximately $1.6 million. Following this issuance, the Company has a remaining capacity to sell up to an additional $92.3 million of the Company's common stock under the Second Equity Distribution Agreement.

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2025

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. Included in this legislation are provisions that allow for the immediate expensing of domestic United States research and development expenses and acceleration of tax deductions for qualified capital expenditures acquired and placed into service after January 19, 2025, and other changes to the U.S. taxation of profits derived from foreign operations. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. We are currently

evaluating the impact of the new legislation but do not anticipate a significant impact to our consolidated financial statements.

During July and August 2025, the Company sold 6,109,714 shares of our common stock under the Second Equity Distribution Agreement at an average price of $13.45 per share for $82.2 million of gross proceeds. The commissions and offering costs borne by the Company were approximately $1.6 million. Following this issuance, the Company has a remaining capacity to sell up to an additional $92.3 million of the Company's common stock under the Second Equity Distribution Agreement.